Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / H. Lee Moffitt Cancer Center & Research Institute
Other

H. Lee Moffitt Cancer Center & Research Institute

Tracked across 1 events · 6 articles · First seen May 12, 2026 · Last active May 12, 2026

Sentiment
20
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 20
Tech
Geron RYTELO LR-MDS Study Results
Geron Corporation announced that the first real-world evidence study of its drug RYTELO (imetelstat) in patients with lower-risk myelodysplastic syndromes (LR-MDS) will be presented at the European Hematology Association (EHA) 2026 Congress. The investigator-sponsored study,…
Impact: H. Lee Moffitt Cancer Center & Research Institute conducted the investigator-sponsored study on RYTELO (imetelstat), contributing to the real-world evidence supporting its efficacy and safety.
May 12, 2026 · 6 articles
Key Actions (1)
60 H. Lee Moffitt Cancer Center & Research Institute conducted studyGeron RYTELO LR-MDS Study Results
NEWSDESK
Track H. Lee Moffitt Cancer Center & Research Institute live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.